MSB 3.21% $1.13 mesoblast limited

Ann: Mesoblast Corporate Update and Financial Results Webcast, page-16

  1. 240 Posts.
    lightbulb Created with Sketch. 123
    Mixed news: Rejection of Type A request and possible partnership with Novartis for ARDS . A rough morning on ASX?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.